Equity
-€33.4m from €20.1m in 2021
Equity fell below zero in 2023.
IMCYSE
Lifetime
14 annual accounts with figures on one time axispeak €1.7m (2014)
-not published
lowest -€32.8m (2023)
-€6.2m▲ €26.6m
peak €20.1m (2021)
-€33.4m▼ €6.2m
€36.3m▲ 28.2%
peak 47.1 FTE (2022)
41.9 FTE▼ 11.0%
Board19 names since 2019all names
1 directorBioPharma Management and Consulting
Owners2 names in the annual accounts
10.18%NOSHAQ
Documentsfilings and deeds
13-08-2024130 days before the deadline
2024financial year
Turnover from €1.1m to €1.5mLoss of €6.2mStaff from 47.1 FTE to 41.9 FTEDissolution of the company 09-09Dissolution of the company 08-08Equity from -€27.1m to -€33.4m
Key points
from the 2024 annual accounts, the last ones filedLosses
-€98.0m in ten years
Every financial year from 2015 to 2024 closed with a loss. 2023 was the heaviest.
Debts
€36.3m 755% of the balance sheet
Financial debts 72%Suppliers 15%Taxes and wages 2%Other 11%
Of this, €32.4m falls due within a year.
Investments
€430,273 0.1 × depreciation
Green is investment, beige is depreciation.
Staff
44 employees on 21-05-2024
In 2024, 8 people joined and 10 left.
Payment terms
307 days to suppliers
IMCYSE pays its suppliers 224 days later than in 2023. Customers pay 65 days earlier.
No scoreNet result +81%: 5-month year
Board and ownership
- BIOGENOSIS 35.51%equity €13.0m (2023) · 2023 annual accounts of BIOGENOSIS
- NOSHAQ 10.18%equity €212.1m (2025) · 30-06-2025 annual accounts of NOSHAQ
Shares in 1 company, Imcyse US, Inc
Board & ownershipRecent changes
Listed in the Peppol Directory
Dissolution of the company
Dissolved on 21-05-2024, in liquidation · Resignations: Tomtaa UG GmbH, SPARAXIS, AS Partners, SVR Invest, Noshaq Partners, BRICHARD Vincent and 1 other · Permanent representatives: TAAPKEN Thomas, FRANSSEN Christine, YEE Stefan, VAN ROMPAY Stijn, WALLEMACQ and BEDORET Denis · General meeting of 26-06-2024 · Gazette deed
Dissolution of the company
Dissolved on 21-05-2024, in liquidation · Liquidator: AYDOGDU Roman · Resignations: Tomtaa UG GmbH, SPARAXIS, AS Partners, SVR Invest, Noshaq Partners, BRICHARD Vincent and 1 other · General meeting of 21-05-2024 · Gazette deed
Amendment of the articles
General meeting of 11-04-2022 · Gazette deed
Official details
Source: KBO- Status
- In liquidation since 21-05-2024deed of 09-09-2024 · founded on 10-08-2010
- Activity
- Research and development on biotechnologyNACE 72101
- Joint committee
- 207White-collar workers in the chemical industry · annual accounts 21-05-2024
- Establishment units
- 2.251.682.7744000 Liège, since 18-07-2013
- 2.320.062.6284031 Liège, since 06-04-2021
- Financial year end
- 21 May
- Peppol
- Reachable since 14-04-2026
Annual accounts to 21-05-2024
- €8.0m▼ 49.4%
- €4.8m▲ 44.8%
- Employeeson 21-05-2024
- 44▼ 4.3%
- Filing
- Filed on 13-08-2024
Insights on IMCYSE
The KBO lists the legal status of IMCYSE as dissolution or liquidation, with no start date. The company was dissolved on 21-05-2024 and put into liquidation. The liquidator is AYDOGDU Roman. The 2024 annual accounts show negative equity (-€33.4m) and a net result of -€6.2m.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about IMCYSE
- What is the company number of IMCYSE?
- The company number of IMCYSE is 0828.385.542. The VAT number is the same number with BE in front: BE 0828.385.542.
- Where was IMCYSE based?
- The last known address of the registered office is Avenue Pré-Aily 14, 4031 Liège.Company details
- What does IMCYSE do?
- According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
- What is the legal form of IMCYSE?
- IMCYSE is a public limited company (NV).
- When was IMCYSE founded?
- IMCYSE was founded on 10-08-2010.
- Is IMCYSE still active?
- No. According to the KBO register, IMCYSE is dissolved or in liquidation.
- How many employees did IMCYSE have?
- IMCYSE had an average of 41.9 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
- Which joint committee does IMCYSE fall under?
- In its 21-05-2024 annual accounts, IMCYSE states joint committee 207 (White-collar workers in the chemical industry).
- What is the turnover of IMCYSE?
- The turnover of IMCYSE was €1.5m in financial year 2024, according to the filed annual accounts.
- Is IMCYSE profitable?
- In financial year 2024, IMCYSE made a loss of €6.2m.
- Where can I find the annual accounts of IMCYSE?
- IMCYSE filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2024.
Next steps
See what became of the directors' other companies.Supplier due diligence See who ran this company and where its registered office was, on a date of your choice.Company as of a date Find how this company is connected to another party.Network investigator See how the research and development on biotechnology sector is doing.Sector figures